With regards to the explanation of no material change requested by IIROC, the same disclaimer was mentioned in the original news release regarding the Pelligrino valuation.


Sorry, I hadn't seen the March 2, 2011 news release, but OPL had already expressed the disclaimer about the 3rd party report, but I guess IIROC needed them to express that there wasn't any material change that warranted the volume and price rise after the report was released.


Either way, the meaning which I'm trying to relay is that there is still risk, and it shouldn't be downplayed, which it seems to be by some on this board. JMO